Registry of Patients Treated With Systemic Mold-Active Triazoles

Official Title: Observational Disease Registry of Patients Treated With Systemic Mold-Active Triazoles

The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).

NCT03066011
Muller, William J., MD, PhD
Observational
Yes

Contact Information:

Laura Fearn

Nurse Coordinator

312.227.6285